- Tytuł:
- Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug
- Autorzy:
- Źródło:
- Journal of Experimental & Clinical Cancer Research. 40(1)
Czasopismo naukowe